Index B
- Babinski's reflex (sign) 422
- Bacille Calmette-Guérin, in bladder cancer 993
- Bacitracin1367t
- Back
- pain in, in abdominal aortic aneurysm 935
- in physical examination 34
- Baclofen
- in pain management 394t
- sexual function and 1164t
- in trigeminal neuralgia 1350
- Bacteremia
- clinical presentation of 39
- during gastrointestinal endoscopy 1006-1007
- in infective endocarditis 879, 882
- Bacteria, intestinal overgrowth of 1002, 1087, 1096, 1098t, 1101
- tests for 1104
- Bacterial infections (see Infection and specific diseases)
- Bacteriuria 983-984 (see also Urinary tract, infection of)
- asymptomatic 980, 981, 984
- catheter-related 985-987, 987t
- Balance (see also Falls; Gait)
- age-related changes in 195
- assessment of 206
- in dizziness 188
- testing of 195
- training for 50t, 304
- in gait disorders 211
- Balanitis 1189-1190, 1189t
- Balloon valvuloplasty 867, 949-950
- Barbiturates
- adverse effects of 65t
- drug interactions with 68t
- in insomnia 457, 458t
- sexual function and 1164t
- Barium enema
- for cancer screening 48t, 718t
- in constipation 1083
- Barium study
- in gastrointestinal tract bleeding 1108
- in intestinal tract obstruction 1115
- Baroreceptor reflex 817-818, 844-845
- Barrett's esophagus 1039, 1040
- adenocarcinoma and 1135
- endoscopy in 1007
- Basal cell carcinoma
- of ears 1343
- of eyelids 1309f
- of skin 1279-1280
- Basal ganglia 429
- Basilar artery 404f-405f
- atherosclerosis of 406, 408t
- Bateman's purpura 1237
- bcr/abl gene 703, 705f
- Bed rest
- adverse effects of 102
- muscle wasting with 512
- in rheumatoid arthritis 501
- Bedsores 1261-1276, 1262t, 1263f, 1265t, 1267f, 1268t, 1272t (see also Pressure sores)
- Behavior
- aging and 308-309
- in delirium 356
- disorders of
- in dementia
359,
361t,
371-377,
373t
- Behavioral therapy
- in depression 319-320
- in insomnia 454, 455t
- in irritable bowel syndrome 1070
- in urinary incontinence 975
- Belladonna alkaloids, adverse effects of 64t
- Belsey repair
- in gastroesophageal reflux disease 1040
- in hiatus hernia 1120
- Benazepril 842t
- Bence Jones protein 734, 735
- Benign paroxysmal positional vertigo 184t, 187f
- Benign prostatic hyperplasia 1179-1183, 1181t
- adverse drug interactions with 67t
- urinary incontinence and 972, 979
- Benign senescent forgetfulness 380
- Bentiromide test 1103
- Benzodiazepines (see also specific drugs)
- adverse effects of 325, 340
- aging effect on 61-62
- in agitation 356
- alcohol interaction with 335
- in alcohol withdrawal 338
- delirium with 352t
- in dementia-related behavior disorders 375
- dependence on 340
- driving and 236
- for dying patient 121-122
- for gastrointestinal endoscopy 1007
- in generalized anxiety disorder 325
- in insomnia 455-456, 457t, 458t
- sexual function and 1163t
- sleep disorders with 451t
- urinary incontinence with 967t
- Benztropine, drug interactions with 69t
- Benzylpenicillin 1367t
- Bereavement 145
- resources about 1413
- Beriberi 590
- Bernstein acid perfusion test 1040
- Beta agonists
- in COPD 786, 787
- Beta blockers 888t
- in angina 856, 857
- cardiac response to, age-related changes in 816t, 820-821
- dosage of 887
- drug interactions with 68t, 69t
- exercise and 305
- in glaucoma 1299, 1300t
- in heart failure 908-909
- in hypertension 843t
- after myocardial infarction 861, 862t, 859
- sleep disorders with 451t
- Betamethasone 1247t
- Betaxolol
- in glaucoma 1300t
- in hypertension 843t
- Bethanechol 979
- Bezoars
- gastric 1050-1051
- small-intestine 1116
- Bezold-Jarisch reflex 179
- Biguanides 631, 635t
- Bile acid, age-related changes in 1005
- Bile acid--binding resins 616-617, 618t-620t
- Bile duct(s)
- calculi of 1012
- endoscopic retrograde cholangiopancreatography of 1011-1013
- iatrogenic stricture of 1128
- retained stones of 1127
- tumors of 1012, 1151-1152
- Bilevel continuous positive airway pressure (BiPAP) 789
- Biliary cirrhosis 1072
- Biliary colic 1125
- Biliary tract, disorders of 39, 1070-1073, 1125-1128
- Bimatoprost 1300t
- Binet staging 731, 731t
- Biofeedback
- in fecal incontinence 1094-1095
- in urinary incontinence 975, 977
- Biopsy
- bone marrow
- in myelodysplastic syndromes 741
- in myelofibrosis 712
- breast 1219
- cervical 1206
- colonic
- in Crohn's disease 1063
- in ulcerative colitis 1059-1060
- endometrial 1194, 1212
- gastric
- in gastritis 1041
- in Ménétrier's disease 1048
- in peptic ulcer disease 1045
- lung, in pulmonary interstitial disease 798
- lymph node
- in breast cancer 1222
- in Hodgkin's disease 744
- muscle 519
- nerve 519
- prostate 1184
- renal 990
- small-bowel 1102-1103
- temporal artery 508
- vulvar 1207
- Bipolar disorder 312-314
- Bismuth subsalicylate
- in diarrhea 1091t
- in Helicobacter pylori infection 1047
- Bisoprolol
- in heart failure 909
- in hypertension 843t
- Bisphosphonates
- in hypercalcemia 579-580
- in osteoporosis 479-480
- in Paget's disease of bone 483, 485t
- Bivalirudin 700
- Bladder
- cancer of 991-994, 991t
- catheter decompression of 979
- hydrodistention of 1188
- incontinence of (see Urinary incontinence)
- infection of (see Urinary tract, infection of)
- protrusion of (cystocele) 1195, 1196f, 1200
- retraining of 975
- stress testing of 974
- Bladder neck
- dysfunction of, in prostatitis 1187
- suspension of 978
- Bladder outlet
- incompetence of 968, 969t, 977-979
- obstruction of 968-969, 969t, 979
- in benign prostatic hyperplasia 1180
- Bleeding (see also Hemorrhage)
- anemia with 675
- after aortic aneurysm repair 1111-1112
- in brain 416-422, 419f, 420t, 421t
- colonic 1111
- diarrhea with 1088
- esophageal 1109
- gastric 1110
- hemorrhoidal 1075
- hepatic 1111
- nasal 1345-1346
- pancreatic 1111
- in peptic ulcer disease 1044
- rectal 1118
- small intestine 1110-1111
- vaginal 1193-1194, 1193t
- estrogen replacement therapy and 1212
- Bleomycin 747t, 752t
- Blepharitis 1310
- seborrheic 1250, 1251
- Blepharoptosis 1310
- Blepharospasm 1310
- Blind loop syndrome 1122-1123
- Blindness (see Vision, loss of)
Blockers (see Alpha blockers)
Blockers (see Beta blockers)
- Blood
- age-related changes in 672-673
- in glaucoma 1297
- hyperviscosity of
- in chronic leukemia 730
- in multiple myeloma 735
- in Waldenström's macroglobulinemia 735, 738, 739
- stasis of 689
- Blood gases
- in COPD 781
- in pulmonary embolism 776
- in respiratory failure 789
- Blood pressure (see also Hypertension; Hypotension)
- age-related increase in 817
- auscultatory gap and 823
- in diabetes mellitus 957, 963
- in dizziness 188
- exercise effects on 822
- food effects on 601
- in hypertension 833, 836
- in hypotension 847
- measurement of 31-32, 47t, 823, 836
- monitoring of 836
- in syncope 178
- Blood urea nitrogen
- in dehydration 562
- in hyponatremia 565t
- Board-and-care facilities 105t, 110-111
- Boerhaave's syndrome 1113
- Bone
- age-related changes in 467-470, 469t, 474
- density of 214, 467, 472
- effects of hormones on 656t
- loss of (see Osteopenia; Osteoporosis)
- measurement of 50t
- fracture of (see Fractures)
- in hypercalcemia 576
- infection of 486-487
- long 213-214
- loss of (see also Osteopenia; Osteoporosis)
- metabolic disease of 472-486, 474f
- metastatic cancer of 1219-1220, 1228
- in multiple myeloma 733, 734
- nonmetabolic disease of 486-489
- Paget's disease of 480-483
- scan of, in fractures 216
- tumors of 481
- Bone marrow
- age-related changes in 672-673
- aspiration of, in acute leukemia 725
- biopsy of
- in myelodysplastic syndromes 741
- in myelofibrosis 712
- in multiple myeloma 733
- transplantation of
- in myelofibrosis 713
- Borborygmi 1114
- Borchardt's triad 1050
- Borg scale 302-303, 303t
- Botulinum toxin
- in achalasia 1036
- in photoaging 1238
- Bouchard's nodes 36, 535
- in erosive osteoarthritis 490, 538
- Boutonnière deformity 36, 537, 538f
- Bowel (see also Colon; Intestine, small)
- age-related changes in 1002-1003
- anoscopy of 1009-1010
- blind loop of 1122-1123
- infarction of 39
- inflammatory disease of 1058-1066, 1061t, 1064t
- irritable 1068-1070
- obstruction of 1113-1117
- sigmoidoscopy of 1009-1010
- Bowen's disease 1277-1278
- Braden scale 1267f
- Bradyarrhythmias 895-900, 895t
- sinus bradycardia 895t, 897-898
- Bradykinesia 435
- Brain
- age-related changes in 380-383, 381t, 382t
- compensatory mechanisms of 382-383
- delirium and (see Delirium)
- dementia and (see Dementia)
- embolism of 413-415
- hemorrhage in 416-423, 419f, 421t
- infarction of (see also Brain, ischemia of)
- ischemia of 402-416, 406t, 407t, 412t (see also Stroke)
- tumors of
- dementia with 371
- parkinsonism with 444t
- weight of 381
- Breast
- cancer of 1217-1228
- estrogen and 655, 716, 1215, 1218
- resources on 1412
- risk of 1217t, 1219t
- screening for 48t, 718t, 1221t
- staging of 1223t-1224t
- treatment of 720t-721t, 1222-1228, 1226t-1227t
- examination of 34, 1221t
- fine-needle aspiration of 1219
- perimenopausal changes in 1209
- reconstruction of 1224
- self-examination of 718t
- Breathing
- sleep-disordered 460-462
- Breath test
- 14C-triolein 1102
- 14C d-xylose 1104
- 14C-glycocholic acid 1104
- lactose-hydrogen 1090
- Bretylium 888t
- Bright light therapy 454
- Brimonidine 1297, 1300t
- Brinzolamide 1300t
- Broca's aphasia 424t, 428
- Bromocriptine 440
- Bromodiphenhydramine, adverse effects of 63t
- Brompheniramine, adverse effects of 63t
- Bronchiolitis obliterans with organizing pneumonia (BOOP) 794t
- Bronchitis
- chronic 779-787, 785
- sexual activity and 1161
- Bronchoalveolar lavage (BAL) 798
- Bronchodilators
- aging effects on 60t
- in COPD 787
- sleep disorders with 451t
- Bronchus (see Lungs)
- Brontophobia 327
- Bruits
- in cardiovascular examination 824
- carotid 34
- Bulbocavernosus reflexes 974
- Bullous pemphigoid 1256-1257
- Bumetanide 60t
- in hypertension839t
- BUN (see Blood urea nitrogen)
- Bundle branch block 895t, 899-900
- Bunion 552
- Bupivacaine 263, 264
- Burch colposuspension 978
- Burkitt's lymphoma 748-749
- Burning mouth syndrome 1017
- Burow's solution 1260
- Bursitis 497-499
- Achilles tendon 547t
- calcaneus 547t
- Buspirone 72, 325-326
- Busulfan
- sexual function and 1164t
- Bypass surgery
- in coronary artery disease 942-944, 945t, 949
- sexual activity and 1161-1162
- extracranial-intracranial 411
- in peripheral atherosclerosis 918-919, 920
|
 |
|
|
|